Mycophenolate mofetil decreases the risk for chronic renal allograft failure.
Meier-Kriesche
H
H
Department of Internal Medicine, University of Michigan, Medical Center, Ann Arbor, Michigan, USA.
Ojo
A O
AO
Arndorfer
J A
JA
Magee
J C
JC
Cibrik
D M
DM
Leichtman
A B
AB
Campbell
D A
DA
Kaplan
B
B
D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000706:statistics & numerical data; D015999:Multivariate Analysis; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016016:Proportional Hazards Models; D012042:Registries; D012307:Risk Factors; D014184:Transplantation, Homologous; D014481:United States / Q000453:epidemiology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine